UP!

News

Can-Fite BioPharma Ltd. -2.8% (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2019 2019-12-27 0.00 -0.90
Q2 2019 2019-08-29 -0.08 -1.20
Q1 2019 2019-06-10 -0.08 -18.00
Q4 2018 2019-04-12 -2.70 -2.70
Q3 2018 2019-01-17 0.00 0.00
Q2 2018 2018-08-31 -0.90 -0.90
Q1 2018 2018-06-01 -0.75 -1.50
Q4 2017 2018-03-23 -1.05 -1.05
Q3 2017 2017-11-27 -0.60 -0.45
Q2 2017 2017-09-01 -1.80 -1.95

Ratings

2016-04-04 Reiterated Rating HC Wainwright Buy $6.00
2016-01-07 Reiterated Rating HC Wainwright Buy $6.00
2015-11-30 Reiterated Rating HC Wainwright Buy $4.00 to $6.00
2015-11-24 Reiterated Rating HC Wainwright Buy $4.00 to $6.00
2015-09-01 Reiterated Rating HC Wainwright Buy $4.00
2015-05-03 Reiterated Rating HC Wainwright Buy $3.00 to $4.00
2015-03-31 Lower Price Target HC Wainwright Buy $7.00 to $3.00
2015-03-30 Downgrade Roth Capital Buy to Neutral $20.00 to $2.40
2015-03-18 Set Price Target Roth Capital Buy $20.00
2014-12-29 Lower Price Target Roth Capital Buy $28.00 to $20.00
2014-11-18 Initiated Coverage HC Wainwright Buy $7.00
2013-12-23 Boost Price Target Roth Capital $28.00
2016-04-04 Reiterated Rating HC Wainwright Buy $6.00
2016-01-07 Reiterated Rating HC Wainwright Buy $6.00
2015-11-30 Reiterated Rating HC Wainwright Buy $4.00 to $6.00
2015-11-24 Reiterated Rating HC Wainwright Buy $4.00 to $6.00
2015-09-01 Reiterated Rating HC Wainwright Buy $4.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks

Comments